Viswanatha Borlingegowda

Dr. Viswanatha Borlingegowda

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2012 in Ear, Nose & Throat Journal
Verified
Journal Article
Open access
PDF file
VBViswanatha Borlingegowda
Viswanatha Borlingegowda
DSDadarao Sumatha
Dadarao Sumatha
MVMaliyappanahalli Siddappa Vijayashree
Maliyappanahalli Siddappa Vijayashree
A comparative clinical study was carried out that included 50 cases of otomycosis in immunocompetent patients and 50 cases of otomycosis in immunocompromised patients. Clinical presentation, predisposing factors, mycologic profile, and treatment outcomes were compared. Aspergillus spp were the most commonly isolated fungi in the immunocompetent group, and Candida albicans in the immunocompromised group. Bilateral involvement was more common in the immunocompromised group. All the patients were treated with topical clotrimazole ear drops. Four patients in the immunocompromised group did not respond to treatment with clotrimazole but were treated successfully with fluconazole ear drops. Three patients had a small tympanic membrane perforation due to otomycosis.

31 July 2015 in Indian Journal of Otolaryngology and Head & Neck Surgery
Verified
Journal Article
Closed access
PDF file
RDR. K. Datta
R. K. Datta
VBViswanatha Borlingegowda
Viswanatha Borlingegowda
MHM. Shree Harsha
M. Shree Harsha

3 January 2011 in Mediterranean Journal of Hematology and Infectious Diseases
Verified
Journal Article
Open access
PDF file
VBViswanatha Borlingegowda
Viswanatha Borlingegowda
KNKhaja Naseeruddin
Khaja Naseeruddin
Otomycosis is a fungal infection of the external ear; middle ear and open mastoid cavity. Meyer first described the fungal infection of the external ear canal in 1884.External ear canal has the ideal warm humid environment for the proliferation of fungus. Although this disease is rarely life threatening, it can presents a challenging and frustrating situation for the otologist and patients due to long term treatment and high rate of recurrence .Otomycosis is seen more frequently in immunocompromised patients as compared to immunocompetent persons. Recurrence rates are high in immunocompromised patients and they need longer duration treatment and complications are more frequent in immunocompromised patients. In the recent years; opportunistic fungal infections are gaining greater importance in human medicine as a result of possibly huge number of immunocompromised patients. In immunocompromised patients, it is important that the treatment of otomycosis be vigorous, to minimize complications such as hearing loss, tympanic membrane perforations and invasive temporal bone infection . Fungal cultures are essential to confirm the diagnosis. Hematological investigations play a very important role in confirming the diagnosis and immunity status of the patients. In diabetic patients with otomycosis, along with antifungal therapy blood sugar levels should be controlled with medical therapy to prevent complications.

1 October 2007 in International Journal of Pediatric Otorhinolaryngology
Verified
Journal Article
Closed access
VBViswanatha Borlingegowda
Viswanatha Borlingegowda

1 June 2007 in Ear, Nose & Throat Journal
Verified
Journal Article
Open access
PDF file
VBViswanatha Borlingegowda
Viswanatha Borlingegowda
LNL. Krishna Nayak
L. Krishna Nayak
SKShamanna Karthik
Shamanna Karthik
Cholesteatoma of the maxillary sinus is a rare condition, but it should be considered in the differential diagnosis of any slowly expanding lesion of the maxillary sinus. Because the keratinizing squamous epithelium continues to desquamate and expand, thereby causing erosion of the surrounding structures, the cholesteatoma sac must be removed completely. We describe a case of cholesteatoma of the maxillary sinus in an 18-year-old woman.

1 July 2010 in Ear, Nose & Throat Journal
Verified
Journal Article
Open access
PDF file
VBViswanatha Borlingegowda
Viswanatha Borlingegowda
Otitic hydrocephalus is a rare intracranial complication of otitis media. It is characterized by elevated cerebrospinal fluid (CSF) pressure with normal CSF biochemistry and without any focal neurologic abnormality other than those related to the increased intracranial pressure. The pathophysiology of this rare condition is unknown. The incidence of intracranial complications was reduced dramatically with the introduction of newer antibiotics, but complicated cases still occur. Serious consequences can ensue if complications are not identified and treated properly. The author reviews the literature on otitic hydrocephalus and describes 2 new cases.